Millisecond-Timescale Optical Control of Neural Dynamics in the Nonhuman Primate Brain

To understand how brain states and behaviors are generated by neural circuits, it would be useful to be able to perturb precisely the activity of specific cell types and pathways in the nonhuman primate nervous system. We used lentivirus to target the light-activated cation channel channelrhodopsin-...

Full description

Bibliographic Details
Main Authors: Han, Xue, Qian, Xiaofeng, Bernstein, Jacob G., Zhou, Huihui, Talei Franzesi, Giovanni, Stern, Patrick, Bronson, Roderick T., Desimone, Robert, Graybiel, Ann M, Boyden, Edward
Other Authors: Massachusetts Institute of Technology. Synthetic Neurobiology Group
Format: Article
Language:en_US
Published: Elsevier B.V. 2012
Online Access:http://hdl.handle.net/1721.1/70046
https://orcid.org/0000-0002-8860-5914
https://orcid.org/0000-0003-3466-8706
https://orcid.org/0000-0002-0419-3351
https://orcid.org/0000-0002-5938-4227
https://orcid.org/0000-0002-8381-7555
https://orcid.org/0000-0001-7132-8706
https://orcid.org/0000-0002-4326-7720
Description
Summary:To understand how brain states and behaviors are generated by neural circuits, it would be useful to be able to perturb precisely the activity of specific cell types and pathways in the nonhuman primate nervous system. We used lentivirus to target the light-activated cation channel channelrhodopsin-2 (ChR2) specifically to excitatory neurons of the macaque frontal cortex. Using a laser-coupled optical fiber in conjunction with a recording microelectrode, we showed that activation of excitatory neurons resulted in well-timed excitatory and suppressive influences on neocortical neural networks. ChR2 was safely expressed, and could mediate optical neuromodulation, in primate neocortex over many months. These findings highlight a methodology for investigating the causal role of specific cell types in nonhuman primate neural computation, cognition, and behavior, and open up the possibility of a new generation of ultraprecise neurological and psychiatric therapeutics via cell-type-specific optical neural control prosthetics.